Sen-Jam Pharmaceutical Underscores the Urgent Need to Revolutionize Pain Management and End the Opioid Epidemic at the 2019 StartUp Health Festival
February 13, 2019 08:00 ET
|
Sen-Jam Pharmaceutical
HUNTINGTON, N.Y., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Sen-Jam Pharmaceutical, a therapeutic company focused on bringing relief to the opioid crisis, was delighted to present at the 2019 StartUp Health...
Sen-Jam Pharmaceutical Reports the Positive Effect of Payer Options and Expanded Coverage for Individuals with Opioid Use Disorder
August 30, 2018 14:53 ET
|
Sen-Jam Pharmaceutical
HUNTINGTON, N.Y., Aug. 30, 2018 (GLOBE NEWSWIRE) -- The Opioid Epidemic is an incredibly complex and multifaceted problem facing America. We wanted to investigate the developments in medications,...
BioCorRx, Inc. Announces New Program and Outlines Growth Strategy in Special Letter to Shareholders
September 17, 2015 08:00 ET
|
BioCorRx
Los Angeles, Sept. 17, 2015 (GLOBE NEWSWIRE) -- Dear Fellow Shareholder,
I am writing today to reintroduce you to BioCorRx, Inc. (OTCQB: BICX) and bring you up to date on our recent progress and our...
BioCorRx to Present at 10th Annual Singular Research Investor Conference on September 17, 2015
September 10, 2015 08:00 ET
|
BioCorRx
Los Angeles, Sept. 10, 2015 (GLOBE NEWSWIRE) -- BioCorRx, Inc. (OTCQX: BICX), developer of the Start Fresh Program, a Medication-Assisted Treatment (MAT) program, today announced that Brady...